High-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection. Article uri icon

Overview

publication date

  • September 15, 2013

Research

keywords

  • Graft Rejection
  • Immunoglobulins, Intravenous
  • Pancreas Transplantation

Identity

Scopus Document Identifier

  • 84883513938

Digital Object Identifier (DOI)

  • 10.1097/TP.0b013e3182a04974

PubMed ID

  • 23995870

Additional Document Info

volume

  • 96

issue

  • 5